Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Valvular Heart Disease

Free Subscription Articles published in Circulation Retrieve available abstracts of 215 articles: HTML format

Single Articles

June 2021
1. DEMER LL, Tintut Y
   Hearts of Stone: Calcific Aortic Stenosis and Antiresorptive Agents for Osteoporosis.
   Circulation. 2021;143:2428-2430.
   PubMed    
   
   
   
2. TAM DY, Wijeysundera HC
   A Real-World Examination of Embolic Protection Devices for Transcatheter Aortic Valve Replacement.
   Circulation. 2021;143:2241-2243.
   PubMed    
   
   
   May 2021
3. KAR S, Mack MJ, Lindenfeld J, Abraham WT, et al
   Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure: The COAPT Trial.
   Circulation. 2021 May 27. doi: 10.1161/CIRCULATIONAHA.120.053061.
   PubMed     Abstract available
   
   
   
4. SHROFF GR, Bangalore S, Bhave NM, Chang TI, et al
   Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart Association.
   Circulation. 2021 May 13:CIR0000000000000979. doi: 10.1161/CIR.0000000000000979.
   PubMed     Abstract available
   
   
   April 2021
5. PAWADE TA, Doris MK, Bing R, White AC, et al
   Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial.
   Circulation. 2021 Apr 29. doi: 10.1161/CIRCULATIONAHA.121.053708.
   PubMed     Abstract available
   
   
   
6. LINDMAN BR, Merryman WD
   Unloading the Stenotic Path to Identifying Medical Therapy for Calcific Aortic Valve Disease: Barriers and Opportunities.
   Circulation. 2021;143:1455-1457.
   PubMed    
   
   
   March 2021
7. KIM WK, Walther T, Burgdorf C, Mollmann H, et al
   One-Year Outcomes of a Randomized Trial Comparing a Self-Expanding With a Balloon-Expandable Transcatheter Aortic Valve.
   Circulation. 2021;143:1267-1269.
   PubMed    
   
   
   
8. CONSTANT DIT BEAUFILS AL, Huttin O, Jobbe-Duval A, Senage T, et al
   Replacement Myocardial Fibrosis in Patients with Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling and Arrhythmia.
   Circulation. 2021 Mar 12. doi: 10.1161/CIRCULATIONAHA.120.050214.
   PubMed     Abstract available
   
   
   
9. 
   Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
   Circulation. 2021;143:e784.
   PubMed    
   
   
   
10. VINCENT F, Ternacle J, Denimal T, Shen M, et al
    Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis.
    Circulation. 2021;143:1043-1061.
    PubMed     Abstract available
    
    
    February 2021
11. BUTALA NM, Makkar R, Secemsky EA, Gallup D, et al
    Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results from the TVT Registry.
    Circulation. 2021 Feb 23. doi: 10.1161/CIRCULATIONAHA.120.052874.
    PubMed     Abstract available
    
    
    
12. WORKMAN V, Forrest JK, Enriquez A
    A Case of Presyncope After Transcatheter Aortic Valve Replacement.
    Circulation. 2021;143:857-861.
    PubMed    
    
    
    
13. SHAH SV, Bavry AA, Kumbhani DJ
    Transcatheter Mitral Valve Edge-to-Edge Repair for Secondary Mitral Regurgitation: Why Sex Matters.
    Circulation. 2021;143:621-623.
    PubMed    
    
    
    
14. 
    Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2021;143:e228.
    PubMed    
    
    
    
15. 
    Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2021;143:e229.
    PubMed    
    
    
    January 2021
16. MESSAS E, IJsselmuiden A, Goudot G, Vlieger S, et al
    Feasibility and Performance of Noninvasive Ultrasound Therapy in Patients With Severe Symptomatic Aortic Valve Stenosis: A First-in-Human Study.
    Circulation. 2021 Jan 25. doi: 10.1161/CIRCULATIONAHA.120.050672.
    PubMed    
    
    
    
17. FORTUNI F, Bax JJ, Delgado V
    Changing the Paradigm in the Management of Valvular Heart Disease: In Addition to Left Ventricular Ejection Fraction, Focus on the Myocardium.
    Circulation. 2021;143:209-211.
    PubMed    
    
    
    
18. URENA M, Vahanian A, Brochet E, Ducrocq G, et al
    Current Indications for Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valves: Valve-in-Valve, Valve-in-Ring, and Valve-in-Mitral Annulus Calcification.
    Circulation. 2021;143:178-196.
    PubMed     Abstract available
    
    
    
19. BAPAT VN
    Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-Mitral Annular Calcification: Are We There Yet?
    Circulation. 2021;143:117-119.
    PubMed    
    
    
    December 2020
20. OTTO CM, Nishimura RA, Bonow RO, Carabello BA, et al
    2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2020 Dec 17:CIR0000000000000923. doi: 10.1161/CIR.0000000000000923.
    PubMed    
    
    
    
21. OTTO CM, Nishimura RA, Bonow RO, Carabello BA, et al
    2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2020 Dec 17:CIR0000000000000932. doi: 10.1161/CIR.0000000000000932.
    PubMed     Abstract available
    
    
    
22. BAVRY AA, Arnaoutakis GJ
    Perspective to 2020 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease.
    Circulation. 2020 Dec 17. doi: 10.1161/CIRCULATIONAHA.120.051501.
    PubMed    
    
    
    
23. MEHMOOD M
    Letter by Mehmood Regarding Article, "Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction".
    Circulation. 2020;142:e375-e376.
    PubMed    
    
    
    
24. PETERZAN MA, Neubauer S, Rodgers CT, Rider OJ, et al
    Response by Peterzan et al to Letter Regarding Article, "Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction".
    Circulation. 2020;142:e377-e378.
    PubMed    
    
    
    November 2020
25. USEINI D, Strauch J
    Letter by Useini and Strauch Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e310-e311.
    PubMed    
    
    
    
26. LOARDI C, Zanobini M
    Letter by Loardi and Zanobini Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e312-e313.
    PubMed    
    
    
    
27. PIBAROT P, Mack MJ, Leon MB, Hahn RT, et al
    Response by Pibarot et al to Letter Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e314-e315.
    PubMed    
    
    
    
28. POLLARI F, Vogt F, Fischlein T
    Letter by Pollari et al Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e308-e309.
    PubMed    
    
    
    
29. KARTHIKEYAN G, Connolly SJ, Yusuf S
    Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation.
    Circulation. 2020;142:1697-1699.
    PubMed    
    
    
    October 2020
30. LURZ P, Unterhuber M, Rommel KP, Kresoja KP, et al
    Closure of Iatrogenic Atrial Septal Defect Following Transcatheter Mitral Valve Repair: The Randomized MITHRAS Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051989.
    PubMed    
    
    
    
31. TAMBURINO C, Bleiziffer S, Thiele H, Scholtz S, et al
    Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051547.
    PubMed     Abstract available
    
    
    
32. DEL VAL D, Linke A, Abdel-Wahab M, Latib A, et al
    Long-Term Outcomes After Infective Endocarditis After Transcatheter Aortic Valve Replacement.
    Circulation. 2020;142:1497-1499.
    PubMed    
    
    
    
33. CHAN V, Mazer CD, Ali FM, Quan A, et al
    Randomized, Controlled Trial Comparing Mitral Valve Repair With Leaflet Resection Versus Leaflet Preservation on Functional Mitral Stenosis: The CAMRA CardioLink-2 Study.
    Circulation. 2020;142:1342-1350.
    PubMed     Abstract available
    
    
    
34. HANZEL GS, Gersh BJ
    Transcatheter Aortic Valve Replacement in Low-Risk, Young Patients: Natural Expansion or Cause for Concern?
    Circulation. 2020;142:1317-1319.
    PubMed    
    
    
    September 2020
35. SIMONATO M, Whisenant B, Barbosa Ribeiro H, Webb JG, et al
    Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement: Comprehensive Mid-Term Evaluation of Valve-in-Valve and Valve-in-Ring Implantation from the VIVID Registry.
    Circulation. 2020 Sep 25. doi: 10.1161/CIRCULATIONAHA.120.049088.
    PubMed     Abstract available
    
    
    August 2020
36. THIELE H, Kurz T, Feistritzer HJ, Stachel G, et al
    General versus Local Anesthesia with Conscious Sedation in Transcatheter Aortic Valve Implantation: The Randomized SOLVE-TAVI Trial.
    Circulation. 2020 Aug 21. doi: 10.1161/CIRCULATIONAHA.120.046451.
    PubMed     Abstract available
    
    
    
37. TUCKER NR, Chaffin M, Bedi KC Jr, Papangeli I, et al
    Myocyte-Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2-Mediated Myocarditis.
    Circulation. 2020;142:708-710.
    PubMed    
    
    
    July 2020
38. MICHELENA HI, Vallabhajosyula S, Prakash SK
    Nosology Spectrum of the Bicuspid Aortic Valve Condition: Complex-Presentation Valvulo-Aortopathy.
    Circulation. 2020;142:294-299.
    PubMed    
    
    
    June 2020
39. ABBAS AE
    Letter by Abbas Regarding Articles, "Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry" and "Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expand
    Circulation. 2020;141:e908-e909.
    PubMed    
    
    
    
40. DEHARO P, Bisson A, Saint Etienne C, Fauchier L, et al
    Response by Deharo et al to Letter Regarding Article, "Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis: Data From a Nationwide Analysis".
    Circulation. 2020;141:e912-e913.
    PubMed    
    
    
    
41. VINCENT F, Ternacle J, Delhaye C, Auffret V, et al
    Response by Vincent et al to Letter Regarding Article, "Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry".
    Circulation. 2020;141:e910-e911.
    PubMed    
    
    
    
42. ARTIACH G, Carracedo M, Plunde O, Wheelock CE, et al
    Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease through the Resolvin E1 and ChemR23 Axis.
    Circulation. 2020 Jun 8. doi: 10.1161/CIRCULATIONAHA.119.041868.
    PubMed     Abstract available
    
    
    
43. TAM DY, Wijeysundera HC, Naimark D, Gaudino M, et al
    Impact of Transcatheter Aortic Valve Durability on Life Expectancy in Low Risk Patients with Severe Aortic Stenosis.
    Circulation. 2020 Jun 4. doi: 10.1161/CIRCULATIONAHA.119.044559.
    PubMed     Abstract available
    
    
    
44. 
    Correction to: Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry.
    Circulation. 2020;141:e879.
    PubMed    
    
    
    May 2020
45. 
    Correction to: Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
    Circulation. 2020;141:e836.
    PubMed    
    
    
    
46. PETERZAN MA, Clarke WT, Lygate CA, Lake HA, et al
    Cardiac Energetics in Patients with Aortic Stenosis and Preserved versus Reduced Ejection Fraction.
    Circulation. 2020 May 22. doi: 10.1161/CIRCULATIONAHA.119.043450.
    PubMed     Abstract available
    
    
    
47. STROM JB, Faridi KF, Butala NM, Zhao Y, et al
    Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings from the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.120.046159.
    PubMed     Abstract available
    
    
    
48. DELGADO V, Kumbhani DJ
    Cardiac and Vascular Changes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Aortic Stenosis.
    Circulation. 2020;141:1538-1540.
    PubMed    
    
    
    April 2020
49. MARSTRAND P, Han L, Day SM, Olivotto I, et al
    Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.
    Circulation. 2020;141:1371-1383.
    PubMed     Abstract available
    
    
    
50. PIBAROT P, Salaun E, Dahou A, Avenatti E, et al
    Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
    Circulation. 2020 Apr 10. doi: 10.1161/CIRCULATIONAHA.119.044574.
    PubMed     Abstract available
    
    
    
51. LI S, Nguyen NUN, Xiao F, Menendez-Montes I, et al
    Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation.
    Circulation. 2020 Apr 10. doi: 10.1161/CIRCULATIONAHA.119.043939.
    PubMed     Abstract available
    
    
    March 2020
52. WEISSLER-SNIR A, Dorian P
    Response by Weissler-Snir and Dorian to Letter Regarding Article, "Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario".
    Circulation. 2020;141:e703-e704.
    PubMed    
    
    
    
53. MADIAS JE
    Letter by Madias Regarding Article, "Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario".
    Circulation. 2020;141:e701-e702.
    PubMed    
    
    
    
54. YADGIR S, Johnson CO, Aboyans V, Adebayo OM, et al
    Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.119.043391.
    PubMed     Abstract available
    
    
    
55. TOEPFER CN, Garfinkel AC, Venturini G, Wakimoto H, et al
    Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy.
    Circulation. 2020;141:828-842.
    PubMed     Abstract available
    
    
    February 2020
56. HALIM SA, Edwards FH, Dai D, Li Z, et al
    Outcomes of Transcatheter Aortic Valve Replacement in Patients with Bicuspid Aortic Valve Disease: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Circulation. 2020 Feb 26. doi: 10.1161/CIRCULATIONAHA.119.040333.
    PubMed     Abstract available
    
    
    January 2020
57. ABDEL-WAHAB M, Thiele H
    Transcatheter Heart Valve Design and Mortality: Truth or Dare?
    Circulation. 2020;141:269-272.
    PubMed    
    
    
    
58. LUETKENS JA, Faron A, Geissler HL, Al-Kassou B, et al
    Opportunistic Computed Tomography Imaging for the Assessment of Fatty Muscle Fraction Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Circulation. 2020;141:234-236.
    PubMed    
    
    
    
59. 
    Correction to: Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study.
    Circulation. 2020;141:e54.
    PubMed    
    
    
    
60. KIM AJ, Xu N, Umeyama K, Hulin A, et al
    Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
    Circulation. 2020;141:132-146.
    PubMed     Abstract available
    
    
    
61. FAYSSOIL A
    Letter by Fayssoil Regarding Article, "Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction".
    Circulation. 2020;141:e1-e2.
    PubMed    
    
    
    December 2019
62. KITKUNGVAN D, Yang EY, El Tallawi KC, Nagueh SF, et al
    Prognostic Implications of Diffuse Interstitial Fibrosis in Asymptomatic Primary Mitral Regurgitation.
    Circulation. 2019;140:2122-2124.
    PubMed    
    
    
    November 2019
63. SLOSTAD BD, Witt CM, O'Leary PW, Maleszewski JJ, et al
    Unicuspid Aortic Valve: Demographics, Comorbidities, Echocardiographic Features, and Long-Term Outcomes.
    Circulation. 2019;140:1853-1855.
    PubMed    
    
    
    
64. VAN BELLE E, Vincent F, Labreuche J, Auffret V, et al
    Balloon-Expandable versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison from The France-TAVI Registry.
    Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.043785.
    PubMed     Abstract available
    
    
    
65. DEHARO P, Bisson A, Herbert J, Lacour T, et al
    Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis: Data from a Nationwide Analysis.
    Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.043971.
    PubMed     Abstract available
    
    
    
66. RAGGI P, Bellasi A, Bushinsky D, Bover J, et al
    Slowing Progression of Cardiovascular Calcification with SNF472 in Patients on Hemodialysis: Results of a Randomized, Phase 2b Study.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044195.
    PubMed     Abstract available
    
    
    October 2019
67. KANEKO T
    Killing Two Birds With One Stone: Complete Percutaneous Approach to Aortic Valve Replacement and Revascularization.
    Circulation. 2019;140:1306-1307.
    PubMed    
    
    
    
68. KATO N, Padang R, Pislaru C, Miranda WR, et al
    Hemodynamics and Prognostic Impact of Concomitant Mitral Stenosis in Patients Undergoing Surgical or Transcatheter Aortic Valve Replacement for Aortic Stenosis.
    Circulation. 2019;140:1251-1260.
    PubMed     Abstract available
    
    
    
69. DONNELLAN E, Alashi A, Johnston DR, Gillinov AM, et al
    Outcomes of Patients With Mediastinal Radiation-Associated Mitral Valve Disease Undergoing Cardiac Surgery.
    Circulation. 2019;140:1288-1290.
    PubMed    
    
    
    
70. RUEL M, Gardner TJ
    Introduction to the 2019 Cardiovascular Surgery-Themed Issue.
    Circulation. 2019;140:1231-1232.
    PubMed    
    
    
    September 2019
71. BONOW RO, Mark DB, O'Gara PT
    Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation.
    Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043408.
    PubMed    
    
    
    
72. BARON SJ, Wang K, Arnold SV, Magnuson EA, et al
    Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.
    Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043275.
    PubMed     Abstract available
    
    
    
73. DESAI MY, Svensson LG
    Chronic Severe Aortic Regurgitation: Should We Lower Operating Thresholds?
    Circulation. 2019;140:1045-1047.
    PubMed    
    
    
    
74. IUNG B, Delgado V, Rosenhek R, Price S, et al
    Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Circulation. 2019 Sep 12. doi: 10.1161/CIRCULATIONAHA.119.041080.
    PubMed     Abstract available
    
    
    
75. BASSO C, Iliceto S, Thiene G, Perazzolo Marra M, et al
    Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death.
    Circulation. 2019;140:952-964.
    PubMed     Abstract available
    
    
    
76. KUNDI H, Faridi KF, Wang Y, Wadhera RK, et al
    Geographic Patterns of Growth for Transcatheter Aortic Valve Replacement in the United States.
    Circulation. 2019;140:969-971.
    PubMed    
    
    
    
77. BENNETT AJ, Carter S, Joglar JA
    A New Tachyarrhythmia in a 60-Year-Old Woman.
    Circulation. 2019;140:965-968.
    PubMed    
    
    
    
78. TANG GHL, Verma S, Bhatt DL
    Transcatheter Aortic Valve Replacement in Low-Risk Patients.
    Circulation. 2019;140:801-803.
    PubMed    
    
    
    
79. SONDERGAARD L, Popma JJ, Reardon MJ, Van Mieghem NM, et al
    Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial.
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.118.039564.
    PubMed     Abstract available
    
    
    August 2019
80. KHIRFAN G, Ahmed MK, Almaaitah S, Almoushref A, et al
    Comparison of Different Methods to Estimate Cardiac Index in Pulmonary Arterial Hypertension.
    Circulation. 2019;140:705-707.
    PubMed    
    
    
    
81. FULMER D, Toomer K, Guo L, Moore K, et al
    Defects in the Exocyst-Cilia Machinery Cause Bicuspid Aortic Valve Disease and Aortic Stenosis.
    Circulation. 2019 Aug 7. doi: 10.1161/CIRCULATIONAHA.119.038376.
    PubMed     Abstract available
    
    
    July 2019
82. AILAWADI G, Lim DS, Grayburn PA
    Response by Ailawadi et al to Letter Regarding Article, "One-Year Outcomes After MitraClip for Functional Mitral Regurgitation".
    Circulation. 2019;140:e175-e176.
    PubMed    
    
    
    
83. GUL EE, Haseeb S
    Letter by Gul and Haseeb Regarding Article, "One-Year Outcomes After MitraClip for Functional Mitral Regurgitation".
    Circulation. 2019;140:e173-e174.
    PubMed    
    
    
    
84. MITAL S, Ommen S
    To Screen or Not to Screen, That Is the Question.
    Circulation. 2019;140:193-195.
    PubMed    
    
    
    
85. SIGWART U
    Therapeutic Myocardial Infarction for Hypertrophic Obstructive Cardiomyopathy: Is It Appropriate?
    Circulation. 2019;140:11-12.
    PubMed    
    
    
    June 2019
86. DIETZ MF, Prihadi EA, van der Bijl P, Goedemans L, et al
    Prognostic Implications of Right Ventricular Remodeling and Function in Patients with Significant Secondary Tricuspid Regurgitation.
    Circulation. 2019 Jun 12. doi: 10.1161/CIRCULATIONAHA.119.039630.
    PubMed     Abstract available
    
    
    
87. PRENDERGAST BD, Redwood SR
    Transcatheter Aortic Valve Replacement.
    Circulation. 2019;139:2724-2727.
    PubMed    
    
    
    
88. MIRTSCHINK P, Bischof C, Pham MD, Sharma R, et al
    Inhibition of the Hypoxia-Inducible Factor 1alpha-Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart Disease.
    Circulation. 2019;139:2778-2792.
    PubMed     Abstract available
    
    
    
89. GUALA A, Rodriguez-Palomares J, Galian-Gay L, Teixido-Tura G, et al
    Partial Aortic Valve Leaflet Fusion Is Related to Deleterious Alteration of Proximal Aorta Hemodynamics.
    Circulation. 2019;139:2707-2709.
    PubMed    
    
    
    
90. FREITAS-FERRAZ AB, Tirado-Conte G, Dagenais F, Ruel M, et al
    Aortic Stenosis and Small Aortic Annulus.
    Circulation. 2019;139:2685-2702.
    PubMed     Abstract available
    
    
    May 2019
91. BENFARI G, Antoine C, Miller WL, Thapa P, et al
    Excess Mortality Associated with Functional Tricuspid Regurgitation Complicating Heart Failure with Reduced Ejection Fraction.
    Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038946.
    PubMed     Abstract available
    
    
    
92. ENRIQUEZ-SARANO M, Michelena HI, Grigioni F
    Treatment of Functional Mitral Regurgitation.
    Circulation. 2019;139:2289-2291.
    PubMed    
    
    
    
93. SMITH GL, Eisner DA
    Calcium Buffering in the Heart in Health and Disease.
    Circulation. 2019;139:2358-2371.
    PubMed     Abstract available
    
    
    
94. REDDY YNV, Nishimura RA
    Paradox of Low-Gradient Aortic Stenosis.
    Circulation. 2019;139:2195-2197.
    PubMed    
    
    
    
95. PACKER M, Grayburn PA
    Contrasting Effects of Pharmacological, Procedural and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure.
    Circulation. 2019 May 1. doi: 10.1161/CIRCULATIONAHA.119.039612.
    PubMed     Abstract available
    
    
    March 2019
96. MARON BJ, Rowin EJ, Maron MS
    Letter by Maron et al Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".
    Circulation. 2019;139:1557-1558.
    PubMed    
    
    
    
97. HO CY, Day SM, Ashley EA, Michels M, et al
    Response by Ho et al to Letter Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".
    Circulation. 2019;139:1559-1560.
    PubMed    
    
    
    
98. LEHMAN SJ, Tal-Grinspan L, Lynn ML, Strom J, et al
    Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.
    Circulation. 2019;139:1517-1529.
    PubMed     Abstract available
    
    
    
99. ENRIQUEZ-SARANO M, Antoine C
    Response by Enriquez-Sarano and Antoine to Letter Regarding Article, "Clinical Outcome of Degenerative Mitral Regurgitation: Critical Importance of Echocardiographic Quantitative Assessment in Routine Practice".
    Circulation. 2019;139:1465-1466.
    PubMed    
    
    
    
100. PAL N
     Letter by Pal Regarding Article, "Clinical Outcome of Degenerative Mitral Regurgitation: Critical Importance of Echocardiographic Quantitative Assessment in Routine Practice".
     Circulation. 2019;139:1463-1464.
     PubMed    
     
     
     
101. MULLENS W, Martens P
     Sacubitril/Valsartan to Reduce Secondary Mitral Regurgitation.
     Circulation. 2019;139:1366-1370.
     PubMed    
     
     
     February 2019
102. SALEEB SF, Gauvreau K, Mayer JE, Newburger JW, et al
     Aortic Valve Replacement With Bovine Pericardial Tissue Valve in Children and Young Adults.
     Circulation. 2019;139:983-985.
     PubMed    
     
     
     
103. CARRIER L
     Making Sense of Inhibiting Nonsense in Hypertrophic Cardiomyopathy.
     Circulation. 2019;139:812-814.
     PubMed    
     
     
     
104. UDELSON JE
     Evaluating and Reducing the Risk of Sudden Death in Hypertrophic Cardiomyopathy.
     Circulation. 2019;139:727-729.
     PubMed    
     
     
     
105. MAURIZI N, Michels M, Rowin EJ, Semsarian C, et al
     Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.
     Circulation. 2019;139:830-833.
     PubMed    
     
     
     
106. SEEGER T, Shrestha R, Lam CK, Chen C, et al
     A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.
     Circulation. 2019;139:799-811.
     PubMed     Abstract available
     
     
     
107. LEE DP, Tan WLW, Anene-Nzelu CG, Lee CJM, et al
     A Robust CTCF-Based Chromatin Architecture Underpins Epigenetic Changes in the Heart Failure Stress-Gene Response.
     Circulation. 2019 Feb 5. doi: 10.1161/CIRCULATIONAHA.118.036726.
     PubMed     Abstract available
     
     
     
108. THYREGOD HGH, Ihlemann N, Jorgensen TH, Nissen H, et al
     Five-Year Clinical and Echocardiographic Outcomes from the Nordic Aortic Valve Intervention (NOTION) Randomized Clinical Trial in Lower Surgical Risk Patients.
     Circulation. 2019 Feb 1. doi: 10.1161/CIRCULATIONAHA.118.036606.
     PubMed     Abstract available
     
     
     January 2019
109. BAUMGARTNER H
     Has the Time Come to Recommend Percutaneous Mitral Edge-to-Edge Repair for Severe Secondary Mitral Regurgitation?
     Circulation. 2019;139:48-50.
     PubMed    
     
     
     
110. AILAWADI G, Lim DS, Mack MJ, Trento A, et al
     One-Year Outcomes After MitraClip for Functional Mitral Regurgitation.
     Circulation. 2019;139:37-47.
     PubMed     Abstract available
     
     
     December 2018
111. KANG DH, Park SJ, Shin SH, Hong GR, et al
     Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study.
     Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.037077.
     PubMed     Abstract available
     
     
     
112. ASGAR AW
     Transcatheter Aortic Valve Replacement and Valve Durability.
     Circulation. 2018;138:2608-2610.
     PubMed    
     
     
     
113. FIORILLI PN, Giri J
     Should Transcatheter Aortic Valve Replacement Be the Procedure of Choice for Intermediate-Risk Patients With Severe Aortic Stenosis?
     Circulation. 2018;138:2624-2626.
     PubMed    
     
     
     
114. DIDIER R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, et al
     Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients.
     Circulation. 2018;138:2597-2607.
     PubMed     Abstract available
     
     
     
115. WERNER N, Zahn R, Beckmann A, Bauer T, et al
     Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve Stenosis.
     Circulation. 2018;138:2611-2623.
     PubMed     Abstract available
     
     
     November 2018
116. BARON SJ, Wang K, House JA, Magnuson EA, et al
     Cost-Effectiveness of Transcatheter vs. Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Intermediate Risk:Results from the PARTNER 2 Trial.
     Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.118.035236.
     PubMed     Abstract available
     
     
     October 2018
117. YAGISHITA A, Goya M, Hirao K
     Simultaneous Recording of the P Wave During Atrial Fibrillation.
     Circulation. 2018;138:2057-2060.
     PubMed    
     
     
     
118. VAKAMUDI S, Jellis C, Mick S, Wu Y, et al
     Sex Differences in the Etiology of Surgical Mitral Valve Disease.
     Circulation. 2018;138:1749-1751.
     PubMed    
     
     
     
119. DONNELLAN E, Krishnaswamy A, Hutt-Centeno E, Johnston DR, et al
     Outcomes of Patients With Mediastinal Radiation-Associated Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
     Circulation. 2018;138:1752-1754.
     PubMed    
     
     
     
120. SPIEWAK M
     Letter by Spiewak Regarding Article, "Prognostic Implications of Magnetic Resonance-Derived Quantification in Asymptomatic Patients With Organic Mitral Regurgitation: Comparison With Doppler Echocardiography-Derived Integrative Approach".
     Circulation. 2018;138:1608-1609.
     PubMed    
     
     
     
121. PENICKA M
     Response by Penicka to Letter Regarding Article, "Prognostic Implications of Magnetic Resonance-Derived Quantification in Asymptomatic Patients With Organic Mitral Regurgitation: Comparison With Doppler Echocardiography-Derived Integrative Approach".
     Circulation. 2018;138:1610-1611.
     PubMed    
     
     
     September 2018
122. URETSKY S, Gillam LD
     Revisiting and Confirming the Prognostic Importance of Effective Regurgitant Orifice Area in Degenerative Mitral Regurgitation.
     Circulation. 2018;138:1327-1329.
     PubMed    
     
     
     
123. GILLAM LD, Koulogiannis KP, Marcoff L
     Bioprosthetic Aortic Valve Deterioration.
     Circulation. 2018;138:986-988.
     PubMed    
     
     
     
124. HOURDAIN J, Clavel MA, Deharo JC, Asirvatham S, et al
     Common Phenotype in Patients With Mitral Valve Prolapse Who Experienced Sudden Cardiac Death.
     Circulation. 2018;138:1067-1069.
     PubMed    
     
     
     
125. SALAUN E, Mahjoub H, Girerd N, Dagenais F, et al
     Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement.
     Circulation. 2018;138:971-985.
     PubMed     Abstract available
     
     
     August 2018
126. COLLI A, Manzan E, Besola L, Bizzotto E, et al
     One-Year Outcomes After Transapical Echocardiography-Guided Mitral Valve Repair.
     Circulation. 2018;138:843-845.
     PubMed    
     
     
     
127. 
     Correction to: Myeloid Cells Remodel the Mitral Valve.
     Circulation. 2018;138:e125.
     PubMed    
     
     
     July 2018
128. GOMES AV
     Spatiotemporal Multi-Omics-Derived Atlas of Calcific Aortic Valve Disease.
     Circulation. 2018;138:394-396.
     PubMed    
     
     
     
129. MUSA TA, Treibel TA, Vassiliou VS, Captur G, et al
     Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium.
     Circulation. 2018 Jul 12. pii: CIRCULATIONAHA.117.032839.
     PubMed     Abstract available
     
     
     
130. SORAJJA P, Ailawadi G
     Argument for Prophylactic, Catheter-Based Repair of Mitral Regurgitation.
     Circulation. 2018;138:125-127.
     PubMed    
     
     
     
131. GOLDFARB M, Lauck S, Webb JG, Asgar AW, et al
     Malnutrition and Mortality in Frail and Non-Frail Older Adults Undergoing Aortic Valve Replacement.
     Circulation. 2018 Jul 5. pii: CIRCULATIONAHA.118.033887.
     PubMed     Abstract available
     
     
     June 2018
132. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
     Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
     Circulation. 2018;137:2635-2650.
     PubMed     Abstract available
     
     
     
133. HYMAN MC, Patel PA, Giri J
     Response by Hyman et al to Letter Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights From the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Car
     Circulation. 2018;137:2545-2546.
     PubMed    
     
     
     
134. SNIECINSKI RM, Mackensen GB, Kertai MD
     Letter by Sniecinski et al Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology
     Circulation. 2018;137:2543-2544.
     PubMed    
     
     
     
135. CREMER S, Nahrendorf M
     Myeloid Cells Remodel the Mitral Valve.
     Circulation. 2018;137:2494-2496.
     PubMed    
     
     
     
136. ROWIN EJ, Maron MS, Maron BJ
     Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
     Circulation. 2018;137:2541-2542.
     PubMed    
     
     
     
137. WANG L, Zhao YT
     Letter by Wang and Zhao Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
     Circulation. 2018;137:2540.
     PubMed    
     
     
     
138. ZHANG L, Xu XM
     Letter by Zhang and Xu Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
     Circulation. 2018;137:2539.
     PubMed    
     
     
     May 2018
139. ANTOINE C, Benfari G, Michelena HI, Malouf JF, et al
     Clinical Outcome of Degenerative Mitral Regurgitation: Critical Importance of Echocardiographic Quantitative Assessment in Routine Practice.
     Circulation. 2018 May 31. pii: CIRCULATIONAHA.117.033173.
     PubMed     Abstract available
     
     
     
140. HENG EL, Diller GP, Gatzoulis MA, Babu-Narayan SV, et al
     Response by Heng et al to Letter Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
     Circulation. 2018;137:2186-2187.
     PubMed    
     
     
     
141. ROMEO JLR, Bogers AJJC, Mokhles MM
     Letter by Romeo et al Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
     Circulation. 2018;137:2184-2185.
     PubMed    
     
     
     
142. CASELLI S, Mango F, Clark J, Pandian NG, et al
     Prevalence and Clinical Outcome of Athletes With Mitral Valve Prolapse.
     Circulation. 2018;137:2080-2082.
     PubMed    
     
     
     April 2018
143. BRAUNWALD E
     Aortic Stenosis: Then and Now.
     Circulation. 2018 Apr 12. pii: CIRCULATIONAHA.118.033408.
     PubMed     Abstract available
     
     
     March 2018
144. SCHLOTTER F, Halu A, Goto S, Blaser MC, et al
     Spatiotemporal Multi-omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving Disease.
     Circulation. 2018 Mar 27. pii: CIRCULATIONAHA.117.032291.
     PubMed     Abstract available
     
     
     
145. DELGADO V, Hundley WG
     Added Value of Cardiovascular Magnetic Resonance in Primary Mitral Regurgitation.
     Circulation. 2018;137:1361-1363.
     PubMed    
     
     
     
146. GHARIBEH L, Komati H, Bosse Y, Boodhwani M, et al
     GATA6 Regulates Aortic Valve Remodeling and its Haploinsufficiency Leads to RL-Type Bicuspid Aortic Valve.
     Circulation. 2018 Mar 22. pii: CIRCULATIONAHA.117.029506.
     PubMed     Abstract available
     
     
     
147. ZAUNER CA, Holshouser JW, Littmann L
     Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease.
     Circulation. 2018;137:1287-1289.
     PubMed    
     
     
     
148. ASCH FM, Vannan MA, Singh S, Khandheria B, et al
     Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial (Repositionable Percutaneous Replacement
     Circulation. 2018 Mar 12. pii: CIRCULATIONAHA.118.034129.
     PubMed     Abstract available
     
     
     
149. ELBAZ-GREENER G, Masih S, Fang J, Ko DT, et al
     Temporal Trends and Clinical Consequences of Wait-Times for Trans-Catheter Aortic Valve Replacement: A Population Based Study.
     Circulation. 2018 Mar 6. pii: CIRCULATIONAHA.117.033432.
     PubMed     Abstract available
     
     
     
150. HO CY, Link MS
     Predicting the Future in Hypertrophic Cardiomyopathy.
     Circulation. 2018;137:1024-1026.
     PubMed    
     
     
     February 2018
151. LJUNGBERG J, Janiec M, Bergdahl IA, Holmgren A, et al
     Proteomic Biomarkers for Incident Aortic Stenosis Requiring Valvular Replacement.
     Circulation. 2018 Feb 27. pii: CIRCULATIONAHA.117.030414.
     PubMed     Abstract available
     
     
     
152. VAN HAGEN IM, Thorne SA, Taha N, Youssef G, et al
     Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease.
     Circulation. 2018;137:806-816.
     PubMed     Abstract available
     
     
     
153. FRENCH KA, Poppas A
     Rheumatic Heart Disease in Pregnancy: Global Challenges and Clear Opportunities.
     Circulation. 2018;137:817-819.
     PubMed    
     
     
     
154. FRIEDMAN DJ, Parzynski CS, Heist EK, Russo AM, et al
     Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry.
     Circulation. 2018 Feb 20. pii: CIRCULATIONAHA.117.032167.
     PubMed     Abstract available
     
     
     January 2018
155. PELLICCIA A, Lemme E, Maestrini V, Di Paolo FM, et al
     Does Sport Participation Worsen the Clinical Course of Hypertrophic Cardiomyopathy? Clinical Outcome of Hypertrophic Cardiomyopathy in Athletes.
     Circulation. 2018;137:531-533.
     PubMed    
     
     
     
156. SABERI S, Day SM
     Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart.
     Circulation. 2018;137:419-421.
     PubMed    
     
     
     
157. DVIR D, Bourguignon T, Otto CM, Hahn RT, et al
     Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.
     Circulation. 2018;137:388-399.
     PubMed     Abstract available
     
     
     
158. GLASER N, Jackson V, Holzmann MJ, Franco-Cereceda A, et al
     Response by Glaser et al to Letter Regarding Article, "Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement".
     Circulation. 2018;137:312-313.
     PubMed    
     
     
     
159. MADIAS JE
     Letter by Madias Regarding Article, "Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement".
     Circulation. 2018;137:310-311.
     PubMed    
     
     
     
160. LEE JKT, Franzone A, Lanz J, Siontis GCM, et al
     Early Detection of Subclinical Myocardial Damage in Chronic Aortic Regurgitation and Strategies for Timely Treatment of Asymptomatic Patients.
     Circulation. 2018;137:184-196.
     PubMed     Abstract available
     
     
     December 2017
161. PENICKA M, Vecera J, Mirica DC, Kotrc M, et al
     Prognostic Implications of Magnetic Resonance - Derived Quantification in Asymptomatic Patients with Organic Mitral Regurgitation: Comparison with Doppler Echocardiography-Derived Integrative Approach.
     Circulation. 2017 Dec 21. pii: CIRCULATIONAHA.117.029332.
     PubMed     Abstract available
     
     
     
162. SPIRITO P
     Atrial Fibrillation in Hypertrophic Cardiomyopathy: New Light on an Old Problem.
     Circulation. 2017;136:2437-2439.
     PubMed    
     
     
     November 2017
163. BROWN CH 4TH, Hasan RK, Brady MB
     Is Less Really More? Conscious Sedation or General Anesthesia for Transcatheter Aortic Valve Replacement.
     Circulation. 2017;136:2141-2143.
     PubMed    
     
     
     
164. ROCHA RV, Manlhiot C, Feindel CM, Yau TM, et al
     Surgical Enlargement of the Aortic Root Does Not Increase the Operative Risk of Aortic Valve Replacement.
     Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.030525.
     PubMed     Abstract available
     
     
     
165. YAMAMOTO M, Shimura T, Hayashida K
     Response by Yamamoto et al to Letter Regarding Article, "Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement".
     Circulation. 2017;136:1987-1988.
     PubMed    
     
     
     
166. JIN-SHAN H, Xue-Bin L
     Letter by Jin-shan and Xue-bin Regarding Article, "Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement".
     Circulation. 2017;136:1985-1986.
     PubMed    
     
     
     
167. REDFORS B, Genereux P
     Response by Redfors and Genereux to Letter Regarding Article, "Stress Testing in Asymptomatic Aortic Stenosis".
     Circulation. 2017;136:1868-1869.
     PubMed    
     
     
     
168. TZANIS G, Charitos C, Nanas S
     Letter by Tzanis et al Regarding Article, "Stress Testing in Asymptomatic Aortic Stenosis".
     Circulation. 2017;136:1866-1867.
     PubMed    
     
     
     October 2017
169. CHOI B, Lee S, Chang EJ, Song JK, et al
     Response by Choi et al to Letters Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".
     Circulation. 2017;136:1672-1673.
     PubMed    
     
     
     
170. BELLIEN J, Kamel S
     Letter by Bellien and Kamel Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".
     Circulation. 2017;136:1670-1671.
     PubMed    
     
     
     
171. KOH KK
     Letter by Koh Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".
     Circulation. 2017;136:1668-1669.
     PubMed    
     
     
     
172. KAPADIA S, Tuzcu EM, Svensson LG
     Anatomy and Flow Characteristics of Neosinus: Important Consideration for Thrombosis of Transcatheter Aortic Valves.
     Circulation. 2017;136:1610-1612.
     PubMed    
     
     
     
173. FUKUNAGA N, Rao V
     Letter by Fukunaga and Rao Regarding Article, "Transcatheter Treatment of Severe Tricuspid Regurgitation With the Edge-to-Edge MitraClip Technique".
     Circulation. 2017;136:1357-1358.
     PubMed    
     
     
     September 2017
174. ROWIN EJ, Hausvater A, Link MS, Abt P, et al
     Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
     Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267.
     PubMed     Abstract available
     
     
     
175. AUFFRET V, Puri R, Urena M, Chamandi C, et al
     Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives.
     Circulation. 2017;136:1049-1069.
     PubMed     Abstract available
     
     
     
176. HYMAN MC, Vemulapalli S, Szeto WY, Stebbins A, et al
     Conscious Sedation versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the NCDR(R) STS/ACC TVT Registry.
     Circulation. 2017 Sep 1. pii: CIRCULATIONAHA.116.026656.
     PubMed     Abstract available
     
     
     July 2017
177. SORAJJA P, Leon MB, Adams DH, Webb JG, et al
     Transcatheter Therapy for Mitral Regurgitation Clinical Challenges and Potential Solutions.
     Circulation. 2017;136:404-417.
     PubMed     Abstract available
     
     
     
178. GLASER N, Jackson V, Holzmann MJ, Franco-Cereceda A, et al
     Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement.
     Circulation. 2017;136:329-331.
     PubMed    
     
     
     June 2017
179. CLARK CR, Bowler MA, Snider JC, Merryman WD, et al
     Targeting Cadherin-11 Prevents Notch1-Mediated Calcific Aortic Valve Disease.
     Circulation. 2017;135:2448-2450.
     PubMed    
     
     
     
180. ABDUL-JAWAD ALTISENT O, Puri R, Regueiro A, Chamandi C, et al
     Predictors and Association with Clinical Outcomes of the Changes in Exercise Capacity Following Transcatheter Aortic Valve Replacement.
     Circulation. 2017 Jun 6. pii: CIRCULATIONAHA.116.026349.
     PubMed     Abstract available
     
     
     May 2017
181. BRANDENBURG VM, Reinartz S, Kaesler N, Kruger T, et al
     Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study.
     Circulation. 2017;135:2081-2083.
     PubMed    
     
     
     
182. REDFORS B, Pibarot P, Gillam LD, Burkhoff D, et al
     Stress Testing in Asymptomatic Aortic Stenosis.
     Circulation. 2017;135:1956-1976.
     PubMed     Abstract available
     
     
     
183. AIKAWA E, Libby P
     A Rock and a Hard Place: Chiseling Away at the Multiple Mechanisms of Aortic Stenosis.
     Circulation. 2017;135:1951-1955.
     PubMed    
     
     
     
184. 
     Correction to: Percutaneous Therapy for Tricuspid Regurgitation: A New Frontier for Interventional Cardiology.
     Circulation. 2017;135:e1041.
     PubMed    
     
     
     
185. HOLMES DR, Mack MJ
     Aortic Valve Bioprostheses: Leaflet Immobility and Valve Thrombosis.
     Circulation. 2017;135:1749-1756.
     PubMed     Abstract available
     
     
     March 2017
186. KAPADIA SR, Krishnaswamy A, Tuzcu EM
     Percutaneous Therapy for Tricuspid Regurgitation: A New Frontier for Interventional Cardiology.
     Circulation. 2017 Mar 23. pii: CIRCULATIONAHA.116.026533.
     PubMed     Abstract available
     
     
     
187. NICKENIG G, Kowalski M, Hausleiter J, Braun D, et al
     Transcatheter Treatment of Severe Tricuspid Regurgitation with the Edge-to-Edge: MitraClip Technique.
     Circulation. 2017 Mar 23. pii: CIRCULATIONAHA.116.024848.
     PubMed     Abstract available
     
     
     
188. CAPOULADE R, Bowdish M, Kron IL, Smith P, et al
     Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".
     Circulation. 2017;135:e785-e786.
     PubMed    
     
     
     
189. POCAR M
     Letter by Pocar Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".
     Circulation. 2017;135:e783-e784.
     PubMed    
     
     
     
190. CAIRNS BJ, Coffey S, Travis RC, Prendergast B, et al
     A Replicated, Genome-Wide Significant Association of Aortic Stenosis With a Genetic Variant for Lipoprotein(a): Meta-Analysis of Published and Novel Data.
     Circulation. 2017;135:1181-1183.
     PubMed    
     
     
     
191. BRIFFA N, Chambers JB
     Biological Valves in Younger Patients Undergoing Aortic Valve Replacement: A Word of Caution.
     Circulation. 2017;135:1101-1103.
     PubMed    
     
     
     
192. WENDLER O, Schymik G, Treede H, Baumgartner H, et al
     SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.
     Circulation. 2017;135:1123-1132.
     PubMed     Abstract available
     
     
     
193. SHIMURA T, Yamamoto M, Kano S, Kagase A, et al
     Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement.
     Circulation. 2017 Mar 16. pii: CIRCULATIONAHA.116.025630.
     PubMed     Abstract available
     
     
     
194. NISHIMURA RA, Otto CM, Bonow RO, Carabello BA, et al
     2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
     Circulation. 2017 Mar 15. pii: CIR.0000000000000503.
     PubMed    
     
     
     February 2017
195. SIONTIS KC, Yao X, Gersh BJ, Noseworthy PA, et al
     Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis.
     Circulation. 2017;135:714-716.
     PubMed    
     
     
     
196. CHOI B, Lee S, Kim SM, Lee EJ, et al
     Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-like Growth Factor-1 Signaling in Valvular Interstitial Cells.
     Circulation. 2017 Feb 8. pii: CIRCULATIONAHA.116.024270.
     PubMed     Abstract available
     
     
     January 2017
197. PRENDERGAST BD, De Bonis M
     Valve Repair: A Durable Surgical Option in Degenerative Mitral Regurgitation.
     Circulation. 2017;135:423-425.
     PubMed    
     
     
     
198. GAMMIE JS, Wilson P, Bartus K, Gackowski A, et al
     Response by Gammie et al to Letter Regarding Article, "Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device: Initial Clinical Experience".
     Circulation. 2017;135:e18-e19.
     PubMed    
     
     
     
199. COLLI A, Gerosa G
     Letter by Colli and Gerosa Regarding Article, "Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device: Initial Clinical Experience".
     Circulation. 2017;135:e16-e17.
     PubMed    
     
     
     
200. BERTRAND PB, Schwammenthal E, Levine RA, Vandervoort PM, et al
     Exercise Dynamics in Secondary Mitral Regurgitation: Pathophysiology and Therapeutic Implications.
     Circulation. 2017;135:297-314.
     PubMed     Abstract available
     
     
     November 2016
201. LAZAM S, Vanoverschelde JL, Tribouilloy C, Grigioni F, et al
     Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation. Analysis of a Large, Prospective, Multicenter International Registry.
     Circulation. 2016 Nov 29. pii: CIRCULATIONAHA.116.023340.
     PubMed     Abstract available
     
     
     
202. MARQUIS-GRAVEL G, Redfors B, Leon MB, Genereux P, et al
     Medical Treatment of Aortic Stenosis.
     Circulation. 2016;134:1766-1784.
     PubMed     Abstract available
     
     
     
203. HELMS AS, Alvarado FJ, Yob J, Tang VT, et al
     Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy.
     Circulation. 2016;134:1738-1748.
     PubMed     Abstract available
     
     
     
204. REYNOLDS MR, Baron SJ, Cohen DJ
     Economic Implications of Transcatheter Aortic Valve Replacement in Patients at Intermediate Surgical Risk.
     Circulation. 2016;134:1416-1418.
     PubMed    
     
     
     October 2016
205. HADJI F, Boulanger MC, Guay SP, Gaudreault N, et al
     Altered DNA Methylation of Long Non-coding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1.
     Circulation. 2016 Oct 27. pii: CIRCULATIONAHA.116.023116.
     PubMed     Abstract available
     
     
     
206. MERRYMAN WD, Clark CR
     Lnc-ing NOTCH1 to Idiopathic Calcific Aortic Valve Disease.
     Circulation. 2016 Oct 27. pii: CIRCULATIONAHA.116.025601.
     PubMed     Abstract available
     
     
     
207. CAPOULADE R, Zeng X, Overbey JR, Ailawadi G, et al
     Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty.
     Circulation. 2016;134:1247-1256.
     PubMed     Abstract available
     
     
     
208. MASRI A, Kalahasti V, Svensson LG, Roselli EE, et al
     Aortic Cross-Sectional Area/Height Ratio and Outcomes in Patients with a Trileaflet Aortic Valve and a Dilated Aorta.
     Circulation. 2016 Oct 21. pii: CIRCULATIONAHA.116.022995.
     PubMed     Abstract available
     
     
     July 2016
209. NGO D, Sinha S, Shen D, Kuhn EW, et al
     Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
     Circulation. 2016;134:270-85.
     PubMed     Abstract available
     
     
     May 2016
210. GANDHI S, Ganame J, Whitlock R, Chu V, et al
     Double Trouble: A Case of Valvular Disease in Pregnancy.
     Circulation. 2016;133:2206-11.
     PubMed    
     
     
     
211. JELLIS CL, Navia JL, Flamm SD, Rodriguez LL, et al
     Severe Functional Tricuspid Stenosis Secondary to a Giant Saphenous Vein Bypass Graft Aneurysm.
     Circulation. 2016;133:2099-102.
     PubMed    
     
     
     
212. HEAD SJ, Mylotte D, Mack MJ, Piazza N, et al
     Considerations and Recommendations for the Introduction of Objective Performance Criteria for Transcatheter Aortic Heart Valve Device Approval.
     Circulation. 2016;133:2086-93.
     PubMed     Abstract available
     
     
     
213. MACINTYRE C, Lakdawala NK
     Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
     Circulation. 2016;133:1901-5.
     PubMed    
     
     
     April 2016
214. MCELHINNEY DB, Cabalka AK, Aboulhosn JA, Eicken A, et al
     Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An International, Multicenter Registry Study.
     Circulation. 2016;133:1582-93.
     PubMed     Abstract available
     
     
     
215. VAHL TP, Hahn RT, Moses JW
     Transcatheter Valve-in-Valve Implantation for Failing Bioprosthetic Triscupid Valves: Completing the Quest.
     Circulation. 2016;133:1537-9.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: